228 related articles for article (PubMed ID: 21511699)
1. Advanced glycation end products (AGEs) increase human mesangial foam cell formation by increasing Golgi SCAP glycosylation in vitro.
Yuan Y; Zhao L; Chen Y; Moorhead JF; Varghese Z; Powis SH; Minogue S; Sun Z; Ruan XZ
Am J Physiol Renal Physiol; 2011 Jul; 301(1):F236-43. PubMed ID: 21511699
[TBL] [Abstract][Full Text] [Related]
2. Enhanced SCAP glycosylation by inflammation induces macrophage foam cell formation.
Zhou C; Lei H; Chen Y; Liu Q; Li LC; Moorhead JF; Varghese Z; Ruan XZ
PLoS One; 2013; 8(10):e75650. PubMed ID: 24146768
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of dysregulation of low-density lipoprotein receptor expression in HepG2 cells induced by inflammatory cytokines.
Chen YX; Ruan XZ; Huang AL; Li Q; Moorhead JF; Varghese Z
Chin Med J (Engl); 2007 Dec; 120(24):2185-90. PubMed ID: 18167199
[TBL] [Abstract][Full Text] [Related]
4. Sirolimus modifies cholesterol homeostasis in hepatic cells: a potential molecular mechanism for sirolimus-associated dyslipidemia.
Ma KL; Ruan XZ; Powis SH; Chen Y; Moorhead JF; Varghese Z
Transplantation; 2007 Oct; 84(8):1029-36. PubMed ID: 17989609
[TBL] [Abstract][Full Text] [Related]
5. Advanced glycation end products (AGEs) increase renal lipid accumulation: a pathogenic factor of diabetic nephropathy (DN).
Yuan Y; Sun H; Sun Z
Lipids Health Dis; 2017 Jun; 16(1):126. PubMed ID: 28659153
[TBL] [Abstract][Full Text] [Related]
6. Cross-talk between TLR4-MyD88-NF-κB and SCAP-SREBP2 pathways mediates macrophage foam cell formation.
Li LC; Varghese Z; Moorhead JF; Lee CT; Chen JB; Ruan XZ
Am J Physiol Heart Circ Physiol; 2013 Mar; 304(6):H874-84. PubMed ID: 23335792
[TBL] [Abstract][Full Text] [Related]
7. Activation of mTOR modulates SREBP-2 to induce foam cell formation through increased retinoblastoma protein phosphorylation.
Ma KL; Liu J; Wang CX; Ni J; Zhang Y; Wu Y; Lv LL; Ruan XZ; Liu BC
Cardiovasc Res; 2013 Dec; 100(3):450-60. PubMed ID: 24068000
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of dysregulation of low-density lipoprotein receptor expression in vascular smooth muscle cells by inflammatory cytokines.
Ruan XZ; Moorhead JF; Tao JL; Ma KL; Wheeler DC; Powis SH; Varghese Z
Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1150-5. PubMed ID: 16543490
[TBL] [Abstract][Full Text] [Related]
9. Difference in LDL receptor feedback regulation in macrophages and vascular smooth muscle cells: foam cell transformation under inflammatory stress.
Ye Q; Lei H; Fan Z; Zheng W; Zheng S
Inflammation; 2014 Apr; 37(2):555-65. PubMed ID: 24297394
[TBL] [Abstract][Full Text] [Related]
10. Advanced glycation end products promote hepatosteatosis by interfering with SCAP-SREBP pathway in fructose-drinking mice.
Mastrocola R; Collino M; Rogazzo M; Medana C; Nigro D; Boccuzzi G; Aragno M
Am J Physiol Gastrointest Liver Physiol; 2013 Sep; 305(6):G398-407. PubMed ID: 23868406
[TBL] [Abstract][Full Text] [Related]
11. Golgi a-mannosidase II mediates the formation of vascular smooth muscle foam cells under inflammatory stress.
Zha K; Ye Q
Folia Histochem Cytobiol; 2021; 59(2):134-143. PubMed ID: 34151999
[TBL] [Abstract][Full Text] [Related]
12. PAQR3 modulates cholesterol homeostasis by anchoring Scap/SREBP complex to the Golgi apparatus.
Xu D; Wang Z; Zhang Y; Jiang W; Pan Y; Song BL; Chen Y
Nat Commun; 2015 Aug; 6():8100. PubMed ID: 26311497
[TBL] [Abstract][Full Text] [Related]
13. An inhibitor of advanced glycation end product formation reduces N epsilon-(carboxymethyl)lysine accumulation in glomeruli of diabetic rats.
Nakamura S; Tachikawa T; Tobita K; Aoyama I; Takayama F; Enomoto A; Niwa T
Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S68-71. PubMed ID: 12612956
[TBL] [Abstract][Full Text] [Related]
14. Advanced glycation end products-induced gene expression of scavenger receptors in cultured human monocyte-derived macrophages.
Iwashima Y; Eto M; Hata A; Kaku K; Horiuchi S; Ushikubi F; Sano H
Biochem Biophys Res Commun; 2000 Oct; 277(2):368-80. PubMed ID: 11032732
[TBL] [Abstract][Full Text] [Related]
15. Dysregulation of LDL receptor under the influence of inflammatory cytokines: a new pathway for foam cell formation.
Ruan XZ; Varghese Z; Powis SH; Moorhead JF
Kidney Int; 2001 Nov; 60(5):1716-25. PubMed ID: 11703589
[TBL] [Abstract][Full Text] [Related]
16. Update on Mechanisms of Renal Tubule Injury Caused by Advanced Glycation End Products.
Sun H; Yuan Y; Sun Z
Biomed Res Int; 2016; 2016():5475120. PubMed ID: 27034941
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory cytokines disrupt LDL-receptor feedback regulation and cause statin resistance: a comparative study in human hepatic cells and mesangial cells.
Chen Y; Ruan XZ; Li Q; Huang A; Moorhead JF; Powis SH; Varghese Z
Am J Physiol Renal Physiol; 2007 Sep; 293(3):F680-7. PubMed ID: 17634396
[TBL] [Abstract][Full Text] [Related]
18. Advanced glycation end product-induced peroxisome proliferator-activated receptor gamma gene expression in the cultured mesangial cells.
Iwashima Y; Eto M; Horiuchi S; Sano H
Biochem Biophys Res Commun; 1999 Oct; 264(2):441-8. PubMed ID: 10529383
[TBL] [Abstract][Full Text] [Related]
19. Analysis of SCAP N-glycosylation and Trafficking in Human Cells.
Cheng C; Guo JY; Geng F; Wu X; Cheng X; Li Q; Guo D
J Vis Exp; 2016 Nov; (117):. PubMed ID: 27911384
[TBL] [Abstract][Full Text] [Related]
20. Advanced glycosylation end products stimulate collagen mRNA synthesis in mesangial cells mediated by protein kinase C and transforming growth factor-beta.
Kim YS; Kim BC; Song CY; Hong HK; Moon KC; Lee HS
J Lab Clin Med; 2001 Jul; 138(1):59-68. PubMed ID: 11433229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
